Timothy Warbington Discloses 13.7% Stake in Creative Medical Technology
Timothy Warbington, President and CEO of Creative Medical Technology Holdings, Inc., disclosed a 13.7% stake in the company’s common stock via a Schedule 13D filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.